136 related articles for article (PubMed ID: 12477868)
21. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
22. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
[TBL] [Abstract][Full Text] [Related]
23. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
[TBL] [Abstract][Full Text] [Related]
24. Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus.
Gupta P; Sharma A; Han J; Yang A; Bhomia M; Knollmann-Ritschel B; Puri RK; Maheshwari RK
BMC Infect Dis; 2017 Apr; 17(1):309. PubMed ID: 28446152
[TBL] [Abstract][Full Text] [Related]
25. The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection.
Amaya M; Keck F; Lindquist M; Voss K; Scavone L; Kehn-Hall K; Roberts B; Bailey C; Schmaljohn C; Narayanan A
PLoS One; 2015; 10(4):e0124792. PubMed ID: 25927990
[TBL] [Abstract][Full Text] [Related]
26. Genetic diversity of Venezuelan alphaviruses and circulation of a Venezuelan equine encephalitis virus subtype IAB strain during an interepizootic period.
Medina G; Garzaro DJ; Barrios M; Auguste AJ; Weaver SC; Pujol FH
Am J Trop Med Hyg; 2015 Jul; 93(1):7-10. PubMed ID: 25940191
[TBL] [Abstract][Full Text] [Related]
27. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
Phillpotts RJ; Lescott TL; Jacobs SC
Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
[TBL] [Abstract][Full Text] [Related]
28. [Establishment of a One-Step Real-Time RT-PCR Method for the Detection of Venezuelan Equine Encephalitis Virus].
Qian S; He B; Tu Z; Guo H; Tu C
Bing Du Xue Bao; 2015 Mar; 31(2):107-13. PubMed ID: 26164934
[TBL] [Abstract][Full Text] [Related]
29. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
Rosas CT; Paessler S; Ni H; Osterrieder N
Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
[TBL] [Abstract][Full Text] [Related]
30. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
[TBL] [Abstract][Full Text] [Related]
31. Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation.
Anishchenko M; Bowen RA; Paessler S; Austgen L; Greene IP; Weaver SC
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4994-9. PubMed ID: 16549790
[TBL] [Abstract][Full Text] [Related]
32. Potential Sympatric Vectors and Mammalian Hosts of Venezuelan Equine Encephalitis Virus in Southern Mexico.
Sotomayor-Bonilla J; Abella-Medrano CA; Chaves A; Álvarez-Mendizábal P; Rico-Chávez Ó; Ibáñez-Bernal S; Rostal MK; Ojeda-Flores R; Barbachano-Guerrero A; Gutiérrez-Espeleta G; Aguirre AA; Daszak P; Suzán G
J Wildl Dis; 2017 Jul; 53(3):657-661. PubMed ID: 28384059
[TBL] [Abstract][Full Text] [Related]
33. Isolation of Complete Equine Encephalitis Virus Genome from Human Swab Specimen, Peru.
Juarez D; Guevara C; Wiley M; Torre A; Palacios G; Halsey ES; Ampuero S; Leguia M
Emerg Infect Dis; 2018 Aug; 24(8):1578-1580. PubMed ID: 30016240
[TBL] [Abstract][Full Text] [Related]
34. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
[TBL] [Abstract][Full Text] [Related]
35. Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection.
Lukaszewski RA; Brooks TJ
J Virol; 2000 Jun; 74(11):5006-15. PubMed ID: 10799574
[TBL] [Abstract][Full Text] [Related]
36. Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion.
Kolokoltsov AA; Fleming EH; Davey RA
Virology; 2006 Apr; 347(2):333-42. PubMed ID: 16427678
[TBL] [Abstract][Full Text] [Related]
37. Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.
Brault AC; Powers AM; Holmes EC; Woelk CH; Weaver SC
J Virol; 2002 Feb; 76(4):1718-30. PubMed ID: 11799167
[TBL] [Abstract][Full Text] [Related]
38. Genetic and evolutionary characterization of Venezuelan equine encephalitis virus isolates from Argentina.
Pisano MB; Torres C; Ré VE; Farías AA; Sánchez Seco MP; Tenorio A; Campos R; Contigiani MS
Infect Genet Evol; 2014 Aug; 26():72-9. PubMed ID: 24833218
[TBL] [Abstract][Full Text] [Related]
39. Altered mitochondrial dynamics as a consequence of Venezuelan Equine encephalitis virus infection.
Keck F; Brooks-Faulconer T; Lark T; Ravishankar P; Bailey C; Salvador-Morales C; Narayanan A
Virulence; 2017 Nov; 8(8):1849-1866. PubMed ID: 28075229
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
